Weight loss drug is not taking easy way out

Oprah Winfrey reveals taking GLP-1 weight-loss drug made her realize what she got wrong about ‘thin people’
The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That changed after a special on weight loss with experts and clinicians that she taped in July 2023. The panel discussion left her with her “biggest aha moment” about the medication.
Oprah Winfrey faces backlash for making bold claim about ‘thin people’ after taking weight-loss drug
"All these years I thought that thin people -- those people -- just had more willpower," Winfrey said on her podcast.
Oprah Winfrey opens up on weight loss, understanding thinness
Oprah Winfrey admitted two years ago to taking diabetes medication to lose weight. In a new podcast episode, she revealed that this process helped her understand "thin" people. Oprah Winfrey has struggled with weight issues for years.
Oprah on taking Ozempic: ‘Weight loss drug is not taking easy way out’
In a discussion with Oprah, Dr Ania called obesity a disease. She also advised that we should treat obesity like other medical conditions.
Oprah Winfrey was ‘publicly humiliated’ due to her weight; speaks on Ozempic, ‘thought thin people had...’
Oprah Winfrey shared that weight-loss medications like Ozempic and Wegovy helped her understand the challenges of being thin. After losing nearly 50 pounds, she emphasized that these drugs assist in managing cravings and support a healthier lifestyle amidst her struggles with weight.
Oprah Winfrey criticised for her latest theory on 'thin people'
The TV queen is being criticised on social media after revealing her new theory on appetite, in light of her experience using a weight-loss drug to shed pounds. "One of the things that I realised the very first time I took a GLP-1 was that all these years I thought that thin people - those people - just had more willpower,
Oprah Winfrey Admits Her Opinion of ‘Thin People’ Changed After Using Drugs Like Ozempic
Oprah Winfrey is opening up about how using weight-loss drugs (like Ozempic, Wegovy and Mounjaro) has impacted the way she views others as well as herself. For a recent episode of The Oprah Podcast, Oprah chatted with endocrinologist and associate professor at the Yale School of Medicine Dr.
The Health Risks and Benefits of Weight-Loss Drugs
T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...
Ozempic and Wegovy: Scientists Uncover New Risks of Popular Weight-Loss “Miracle Drugs”
GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...
Massive study looks at benefits, risks of GLP-1 weight-loss drugs
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
phillyvoice.com21h
Ozempic and Wegovy are helping many Americans lose weight, but they also may have other beneficial uses
News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...
A woman regained weight after she stopped taking semaglutide. Now she works 2 jobs to afford it.
A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started ...
What’s behind the meteoric rise of weight-loss drugs in Massachusetts?
About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...
Medicare to negotiate price of Ozempic, Wegovy weight-loss drugs
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
Wegovy at Higher Dose Achieves Greater Weight Loss in Trial
Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...
STAT6d
High-dose Wegovy leads to substantial weight loss in trial, but falls short of Zepbound
A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...
Medicare to Negotiate Lower Prices for Weight-Loss Drugs
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...
Medicare targets popular weight loss drugs Ozempic, Wegovy for price negotiations
The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...